Position in ABBV
as of Jun 30, 2026
· filed Aug 7, 2026
Position Value
$8,173,770
+$983,769 QoQ
Shares Held
32,482
-1.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.68%
of 13F equity value
Holder Rank
#1,025
of 4,153 holders
Holding Since
Jun 2020
24 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Principle Wealth Partners LLC holds $78,818,305 across 10 Drug Manufacturers - General names. ABBV ranks #5 (10.4% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
112,674 | $28,615,815 | |
| 2 | LLY |
ELI LILLY & Co
|
11,921 | $14,298,406 | |
| 3 | AMGN |
Amgen Inc
|
31,526 | $11,416,195 | |
| 4 | MRK |
Merck & Co., Inc.
|
79,812 | $10,255,842 | |
| 5 | ABBV |
AbbVie Inc.
This page
|
32,482 | $8,173,770 | |
| 6 | PFE |
Pfizer Inc
|
160,668 | $3,868,885 | |
| 7 | NVS |
Novartis AG
|
4,772 | $747,867 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
11,000 | $633,820 |
All Filings in ABBV
Export CSV
24 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $8,173,770 | 32,482 | Shares | Sole | 2026-08-07 | |
| 2026-03-31 | $7,190,001 | 33,059 | Shares | Sole | 2026-05-07 | |
| 2025-12-31 | $7,530,116 | 32,956 | Shares | Sole | 2026-02-06 | |
| 2025-09-30 | $7,625,769 | 32,935 | Shares | Sole | 2025-11-03 | |
| 2025-06-30 | $6,088,892 | 32,803 | Shares | Sole | 2025-07-30 | |
| 2025-03-31 | $6,942,654 | 33,136 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $5,997,552 | 33,751 | Shares | Sole | 2025-01-29 | |
| 2024-09-30 | $6,644,412 | 33,646 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $5,788,113 | 33,746 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $6,262,965 | 34,393 | Shares | Sole | 2024-04-23 | |
| 2023-12-31 | $5,231,012 | 33,755 | Shares | Sole | 2024-02-05 | |
| 2023-09-30 | $4,958,779 | 33,267 | Shares | Sole | 2023-11-01 | |
| 2023-06-30 | $4,301,524 | 31,927 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $5,140,001 | 32,252 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $5,574,090 | 34,491 | Shares | Defined | 2023-02-02 | |
| 2022-09-30 | $4,905,106 | 36,548 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $5,627,557 | 36,743 | Shares | Defined | 2022-08-02 | |
| 2022-03-31 | $6,142,185 | 37,889 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $5,166,457 | 38,157 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $4,089,135 | 37,908 | Shares | Defined | 2021-11-16 | |
| 2021-06-30 | $4,251,708 | 37,746 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $4,049,916 | 37,423 | Shares | Defined | 2021-05-18 | |
| 2020-12-31 | $3,729,355 | 34,805 | Shares | Defined | 2021-02-16 | |
| 2020-06-30 | $301,314 | 3,069 | Shares | Sole | 2020-08-14 | |
| No filing history on record for this holder in this stock. | ||||||